PureTech Health (UK) Performance
| PRTC Stock | 121.20 -2.00 -1.62% |
The firm maintains a market beta of 0.053, which implies relatively modest fluctuations relative to the market. Returns on PureTech Health tend to trail the broader market in strong rallies but hold up better when sentiment turns negative. At this point, PureTech Health plc has a negative expected return of -0.0023%. Please make sure to verify PureTech Health's the relationship between the potential upside and kurtosis, to decide if PureTech Health plc's performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weak
Weak | Strong |
PureTech Health plc has delivered negative risk-adjusted returns across the last 90 days, suggesting that volatility was not compensated by return. This reading is usually reviewed beside volatility, downside risk, and benchmark-relative behavior before conviction is increased. In spite of comparatively stable basic indicators, PureTech Health is not utilizing all of its potential. The newest price uproar may contribute to short-horizon losses for private investors. Learn More
1 | REG - Pure Tech Health PLC - Pure Tech Appoints Robert Lyne as CEO - Trading View Track All Markets | 12/17/2025 |
2 | Pure Tech Health stock hits 52-week low at 16.81 amid market shifts - MSN | 01/12/2026 |
3 | Is Pure Tech Health plc Depositary Receipt attractive for institutional investors - Gap Up Reliable Breakout Stock Forecasts - mfd.ru | 02/17/2026 |
4 | Pure Tech Health plc Stock Analysis Unveiling the Impressive 542.70 percent Revenue Growth in Biotech Innovation - Directors Talk Interviews | 02/27/2026 |
5 | Movement as an Input in Quant Signal Sets - Stock Traders Daily | 03/13/2026 |
| Begin Period Cash Flow | 191.1 M | |
| Total Cashflows From Investing Activities | 240.9 M |
PureTech |
Relative Risk vs. Return Landscape
If you had invested GBX 12,220 in PureTech Health plc on December 15, 2025 and sold it today you would have lost GBX 100.00 from holding PureTech Health plc or given up 0.82% of portfolio value over 90 days. PureTech Health plc is generating negative expected returns and shows 1.4819% volatility on return distribution over a 90-day horizon. Simply put, 13% of stocks are less volatile than PureTech, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
For PureTech Stock, the observed tendency of price to return to a central value is a key input to forecasting models. This mean reversion pattern, however, does not apply uniformly - some stocks remain mispriced for extended periods, suggesting that embedded risk premiums affect the speed of correction.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 121.20 | 90 days | 121.20 | about 92.69 |
According to a normal distribution model, the odds of PureTech Health moving above the current price in 90 days from now are about 92.69 (The density curve for PureTech Health plc shows where PureTech Stock price is most likely to settle within 90 days).
PureTech Health Price Density |
| Price |
Predictive Modules for PureTech Health
A wide range of forecasting techniques can be applied to PureTech Health plc and the broader stock market. While market prediction remains inherently uncertain, combining multiple approaches and evaluating their results is one of the most effective ways to improve the quality of investment decisions.Mean reversion in PureTech Health is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
Primary Risk Indicators
The stock market's recent history has been defined by volatility, with multiple large corrections and rallies in the last 10-20 years. PureTech Health has participated in these swings. Investors holding PureTech Health plc can protect their portfolios by monitoring PureTech Health's risk indicators and implementing appropriate hedging strategies.α | Alpha over Dow Jones | -0.051 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 4.48 | |
Ir | Information ratio | -0.0058 |
Investor Alerts and Insights
Investors in PureTech Health benefit from automated alerts that flag material stock changes as they occur. PureTech Health plc notifications cover technical signals, fundamental shifts, and notable headlines that may impact investment timing.| PureTech Health plc generated a negative expected return over the last 90 days | |
| PureTech Health generates negative cash flow from operations | |
| About 72.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Movement as an Input in Quant Signal Sets - Stock Traders Daily |
Price Density Drivers
Key market indicators for PureTech Health reflect the tension between long and short positioning, along with broader investor sentiment. Reviewing the table below helps investors assess the current dynamics driving PureTech Health's price behavior.
| Common Stock Shares Outstanding | 269.7 M | |
| Cash And Short Term Investments | 367.3 M |
PureTech Health Fundamentals Growth
The market prices PureTech Stock according to PureTech Health's ability to generate revenue growth, maintain healthy margins, and manage debt effectively. These fundamental drivers have a direct and measurable impact on PureTech Stock performance.
| Return On Equity | 0.0944 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | 7.93 % | |||
| Operating Margin | -25.90 % | |||
| Current Valuation | 67.9 M | |||
| Shares Outstanding | 241.81 M | |||
| Price To Book | 1.04 X | |||
| Price To Sales | 45.86 X | |||
| Revenue | 4.32 M | |||
| Gross Profit | -48.81 M | |||
| EBITDA | 37.38 M | |||
| Net Income | 27.78 M | |||
| Total Debt | 159.14 M | |||
| Book Value Per Share | 1.18 X | |||
| Cash Flow From Operations | -134.37 M | |||
| Earnings Per Share | 0.13 X | |||
| Total Asset | 602.63 M | |||
| Retained Earnings | 32.49 M | |||
Performance Metrics & Calculation Methodology
PureTech Health performance is measured on a risk-adjusted basis against benchmarks. Liquidity conditions can influence realized performance through spreads and execution cost. PureTech Health shows ROE of 9.44%, ROA of -12.95%.
The analytics block for PureTech Health plc relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. Return and risk statistics are calculated from historical price series.